Olamufloxacin. Hokuriku Seiyaku.

Abstract

Hokuriku is developing olamufloxacin, a quinolone antibiotic that inhibits DNA gyrase, for the potential treatment of various types of bacterial infection. It has reached late phase II clinical trials. An intravenous formulation is also under investigation [277817].

• Authors: N Jiraskova
• Journal: Current opinion in investigational drugs (London, England : 2000) (Curr Opin Investig Drugs) Vol. 1 Issue 1 Pg. 31-4 (Sep 2000) ISSN: 1472-4472 [Print] England
• PMID: 11249592 (Publication Type: Journal Article, Review)

Chemical References

• Anti-Infective Agents
• Drugs, Investigational
• Fluoroquinolones
• Quinolones
• olamufloxacin

Topics

• Animals
• Anti-Infective Agents (chemical synthesis, pharmacokinetics, pharmacology, toxicity)
• Clinical Trials as Topic
• Drugs, Investigational (chemical synthesis, pharmacokinetics, pharmacology, toxicity)
• Fluoroquinolones
• Humans
• Quinolones (chemical synthesis, pharmacokinetics, pharmacology, toxicity)
• Structure-Activity Relationship